Literature DB >> 19659624

Relevance of echocardiographic evaluation of right ventricular function in patients undergoing cardiac resynchronization therapy.

Lea Scuteri1, Roberto Rordorf, Nina Ajmone Marsan, Maurizio Landolina, Giulia Magrini, Catherine Klersy, Folco Frattini, Barbara Petracci, Alessandro Vicentini, Carlo Campana, Luigi Tavazzi, Stefano Ghio.   

Abstract

AIMS: Right ventricular (RV) dysfunction is a marker of poor prognosis in heart failure (HF) patients. It is still unclear whether RV function might influence response to cardiac resynchronization therapy (CRT).
METHODS: Forty-four consecutive patients with HF, large QRS, and either intraventricular or interventricular dyssynchrony underwent echocardiographic evaluation before, 1 month after, and 6 months after CRT. Response to CRT was considered in case of significant LV reverse remodeling, defined as the occurrence of LV end-systolic volume (LVESV) reduction > or =15% at 6 months.
RESULTS: All echocardiographic indexes of baseline RV function and dimensions were significantly more impaired in nonresponders versus responders to CRT: tricuspid annular plane systolic excursion (TAPSE 15 +/- 4 mm vs 20 +/- 5 mm, P = 0.001), RV systolic pulmonary artery pressure (RVSP 39 +/- 14 mmHg vs 27 +/- 8 mmHg, P = 0.02), RV end-diastolic area (RVEDA 23 +/- 6 cm(2) vs 16 +/- 3 cm(2) P < 0.001), RV end-systolic area (RVESA 16 +/- 6 cm(2) vs 8 +/- 2 cm(2), P = 0.001), and RV fractional area change (30 +/- 12% vs 48 +/- 8%, P < 0.001). All the indexes of RV function significantly correlated with the percentage of LVESV reduction after CRT. Severe RV dysfunction was defined as TAPSE < or =14 mm and the population was stratified into two groups based on baseline TAPSE < or = or > 14 mm. As compared to those with high TAPSE (n = 30), patients with low TAPSE (n = 14) were less likely to show LV reverse remodeling after CRT (76% vs 14%, P < 0.001).
CONCLUSIONS: Our study suggests that RV function significantly affects response to CRT. Poor LV reverse remodeling occurs after CRT in patients with HF having severe RV dysfunction at baseline.

Entities:  

Mesh:

Year:  2009        PMID: 19659624     DOI: 10.1111/j.1540-8159.2009.02436.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  15 in total

Review 1.  Cardiac resynchronization therapy: the issue of non-response.

Authors:  Luigi Padeletti; Alessandro Paoletti Perini; Edoardo Gronda
Journal:  Heart Fail Rev       Date:  2012-01       Impact factor: 4.214

2.  Effects of cardiac resynchronization therapy on right ventricular function during rest and exercise, as assessed by radionuclide angiography, and on NT-proBNP levels.

Authors:  Cinzia Valzania; Mauro Biffi; Rachele Bonfiglioli; Francesco Fallani; Cristian Martignani; Igor Diemberger; Matteo Ziacchi; Jessica Frisoni; Luciana Tomasi; Stefano Fanti; Claudio Rapezzi; Giuseppe Boriani
Journal:  J Nucl Cardiol       Date:  2017-06-30       Impact factor: 5.952

3.  Cardiac resynchronization therapy in chronic heart failure: Effect on right ventricular function.

Authors:  Dominik C Benz; Aju P Pazhenkottil
Journal:  J Nucl Cardiol       Date:  2017-06-28       Impact factor: 5.952

Review 4.  Clinical, laboratory, and pacing predictors of CRT response.

Authors:  Jagdesh Kandala; Robert K Altman; Mi Young Park; Jagmeet P Singh
Journal:  J Cardiovasc Transl Res       Date:  2012-02-24       Impact factor: 4.132

Review 5.  Changes in parameters of right ventricular function with cardiac resynchronization therapy.

Authors:  Abhishek Sharma; Carl J Lavie; Ajay Vallakati; Akash Garg; Sunny Goel; Jason Lazar; Gregg C Fonarow
Journal:  Clin Cardiol       Date:  2017-09-12       Impact factor: 2.882

6.  Association between red blood cell distribution width and response to cardiac resynchronization therapy.

Authors:  Umut Celikyurt; Aysen Agacdiken; Tayfun Sahin; Guliz Kozdag; Ahmet Vural; Dilek Ural
Journal:  J Interv Card Electrophysiol       Date:  2012-06-12       Impact factor: 1.900

7.  Reference values of right ventricular end-diastolic area defined by ethnicity and gender in a young adult population: the CARDIA study.

Authors:  Kofo O Ogunyankin; Kiang Liu; Donald M Lloyd-Jones; Laura A Colangelo; Julius M Gardin
Journal:  Echocardiography       Date:  2011-01-07       Impact factor: 1.724

8.  Pre-implant right ventricular function might be an important predictor of the response to cardiac resynchronization therapy.

Authors:  Magnus Edner; Margareta Ring; Peter Henriksson
Journal:  Cardiovasc Ultrasound       Date:  2011-10-26       Impact factor: 2.062

9.  Prognostic Role of Right Ventricular Function in Patients With Heart Failure Undergoing Cardiac Resynchronization Therapy.

Authors:  Antonio Rapacciuolo; Stefano Maffè; Pietro Palmisano; Anna Ferraro; Antonella Cecchetto; Antonio D'Onofrio; Francesco Solimene; Paola Musatti; Paola Paffoni; Francesca Esposito; Umberto Parravicini; Alessia Agresta; Giovanni Luca Botto; Maurizio Malacrida; Giuseppe Stabile
Journal:  Clin Cardiol       Date:  2016-07-28       Impact factor: 2.882

10.  Right ventricular dysfunction is a predictor of non-response and clinical outcome following cardiac resynchronization therapy.

Authors:  Francisco Alpendurada; Kaushik Guha; Rakesh Sharma; Tevfik F Ismail; Amy Clifford; Winston Banya; Raad H Mohiaddin; Dudley J Pennell; Martin R Cowie; Theresa McDonagh; Sanjay K Prasad
Journal:  J Cardiovasc Magn Reson       Date:  2011-10-31       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.